|
|
| Peripheral Neuropathy and Neuropathic Pain, 2008 |
|
| Table of Contents Published: 2008/01 Published by: BioPharm Reports (Technology and Markets Ltd) |
| This report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals globally. PN and NP are causally linked to a number of diseases, however diabetes, cancer and HIV alone are expected to increase the prev ... |
| Emerging Drug Targets in Alzheimer's Disease |
|
| Table of Contents Published: 2007/12 Published by: Decision Resources, Inc. |
| The lack of effective treatments for Alzheimer' s disease (AD) and an aging population create an enormous opportunity for disease-modifying drugs. Competition to develop new drugs for AD is in fact fi erce, and the effi cacy bar for current AD therapies i ... |
| Gene Expression Profiling Markets |
|
| Table of Contents Published: 2007/12 Published by: Kalorama Information |
| Parts of the gene expression analysis market continue to develop in a somewhat predictable manner, whereas other segments are becoming increasingly complex and volatile. The main products- microarrays and RT-PCR- continue to gain widespread acceptance and ... |
| Marketing to Life Scientists -- Exploring China & India |
|
| Table of Contents Published: 2007/12 Published by: BioInformatics, LLC |
| China and India are two promising emerging markets for life science products. Understanding the best media to reach the decision makers in these countries, how they view leading life science suppliers, and what influences their purchasing decisions is cri ... |
| U.S. Cardiac Biomarkers Diagnostics Markets |
|
| Table of Contents Published: 2007/12 Published by: Frost & Sullivan |
| This research service analyzes the market for cardiac biomarkers within the United States. The United States market was divided into the acute myocardial infarction diagnostics and congestive heart failure diagnostics market segments. ... |
| Antibody Drug Targets and Focus on Breast- & Prostate Cancer |
|
| Table of Contents Published: 2007/11 Published by: BioSeeker Group AB |
| In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug target, Breast- and Prostate cancer, which are all subjects to an extensive number of innovative drug candidates. This extensive 380 ... |
| Business Strategies for Different Types of Biogenerics |
|
| Table of Contents Published: 2007/11 Published by: Decision Resources, Inc. |
| The rush to develop and market biogenerics has begun. While the United States dragged its feet drafting legislation to codify issues surrounding biogenerics, biogenerics companies have successfully brought products to several other markets around the worl ... |
| Drug Discovery Technologies |
|
| Table of Contents Published: 2007/11 Published by: BCC Research |
| This study examines trends in drug discovery. Drug discovery is an enormous field, and this report focuses on a selection of the major workhorse technologies, including liquid chromatography and mass spectrometry, as well as on newer approaches, such as s ... |
| European Protein Purification Markets |
|
| Table of Contents Published: 2007/11 Published by: Frost & Sullivan |
| This Frost & Sullivan research service titled European Protein Purification Markets provides detailed analysis of protein purification products market together with their revenues for each segment. ... |
| RNAi Therapeutics 2008 Market Report |
|
| Table of Contents Published: 2007/11 Published by: Select Biosciences, Ltd. |
| This is the latest RNAi-based Therapeutics Market Report from Select Biosciences. This report presents an up-to-date thorough analysis of the RNAi therapeutics landscape based upon our continuing coverage of this dynamic marketplace. ... |
| World Biosensors Markets |
|
| Table of Contents Published: 2007/10 Published by: Frost & Sullivan |
| The biosensor industry has been making rapid strides for the past few years. Biosensors are increasingly being used for a large number of diverse applications ranging from home diagnostics to security and biodefence. ... |
|
|